PDE News and Research

RSS
RELAX study finds no beneficial effects of erectile dysfunction drug for diastolic heart failure

RELAX study finds no beneficial effects of erectile dysfunction drug for diastolic heart failure

Sildenafil does not improve exercise capacity in HF patients with preserved ejection fraction

Sildenafil does not improve exercise capacity in HF patients with preserved ejection fraction

PDE model identifies contaminants in water distribution networks

PDE model identifies contaminants in water distribution networks

S1 Biopharma announces foray into male sexual health with S1P-205

S1 Biopharma announces foray into male sexual health with S1P-205

Non-invasive imaging technique measures specific brain chemical changes

Non-invasive imaging technique measures specific brain chemical changes

Virginia uproar frames abortion, contraception legislation in many states

Virginia uproar frames abortion, contraception legislation in many states

Novel bipartite gene therapy for retinitis pigmentosa

Novel bipartite gene therapy for retinitis pigmentosa

Sagene completes SPI-1972 pre-IND meeting with FDA for erectile dysfunction

Sagene completes SPI-1972 pre-IND meeting with FDA for erectile dysfunction

Glenmark commences Revamilast Phase IIb trial in chronic inflammatory disorders

Glenmark commences Revamilast Phase IIb trial in chronic inflammatory disorders

Anacor Pharmaceuticals initiates AN2728, AN2898 Phase 2 trial in mild-to-moderate atopic dermatitis

Anacor Pharmaceuticals initiates AN2728, AN2898 Phase 2 trial in mild-to-moderate atopic dermatitis

biocrea and Pfizer jointly presented details on novel PDE10 inhibitors

biocrea and Pfizer jointly presented details on novel PDE10 inhibitors

New insight into Duchenne muscular dystrophy

New insight into Duchenne muscular dystrophy

FDA approves roflumilast to treat COPD

FDA approves roflumilast to treat COPD

New drug approved for COPD by the FDA

New drug approved for COPD by the FDA

Preliminary results from Phase 1b/2a trial of MediciNova's ibudilast in opioid addicts announced

Preliminary results from Phase 1b/2a trial of MediciNova's ibudilast in opioid addicts announced

Forest Laboratories second quarter net sales increase 7.7% to $1,037.3 million

Forest Laboratories second quarter net sales increase 7.7% to $1,037.3 million

Palatin reports positive results from bremelanotide Phase 1 trial for sexual dysfunction

Palatin reports positive results from bremelanotide Phase 1 trial for sexual dysfunction

Mediomics receives additional $460,000 in STTR Phase II grant for PINCER protein assay development

Mediomics receives additional $460,000 in STTR Phase II grant for PINCER protein assay development

PerkinElmer launches innovative solutions platform for Low Light Level Detection applications

PerkinElmer launches innovative solutions platform for Low Light Level Detection applications

CombinatoRx reports $41.3M total revenue for first-quarter 2010

CombinatoRx reports $41.3M total revenue for first-quarter 2010